499 related articles for article (PubMed ID: 18311793)
1. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
2. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
3. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
4. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
5. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
6. The role of RORα in salivary gland lesions in patients with primary Sjögren's syndrome.
Weng X; Liu Y; Cui S; Cheng B
Arthritis Res Ther; 2018 Sep; 20(1):205. PubMed ID: 30189901
[TBL] [Abstract][Full Text] [Related]
7. IL-17 and CCR9
Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML
Front Immunol; 2021; 12():721453. PubMed ID: 34539657
[TBL] [Abstract][Full Text] [Related]
8. IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.
Ciccia F; Alessandro R; Rodolico V; Guggino G; Raimondo S; Guarnotta C; Giardina A; Sireci G; Campisi G; De Leo G; Triolo G
Rheumatology (Oxford); 2013 Jun; 52(6):1009-17. PubMed ID: 23392590
[TBL] [Abstract][Full Text] [Related]
9. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
Jin JO; Shinohara Y; Yu Q
PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
11. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
12. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice.
Jin JO; Kawai T; Cha S; Yu Q
Arthritis Rheum; 2013 Aug; 65(8):2132-42. PubMed ID: 23666710
[TBL] [Abstract][Full Text] [Related]
14. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB
Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in a murine model of Sjögren's syndrome.
Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
Baban B; Liu JY; Abdelsayed R; Mozaffari MS
Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.
Zhou J; Jin JO; Patel ES; Yu Q
Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211
[TBL] [Abstract][Full Text] [Related]
20. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
